8-K Q4 2020

Company

ENANTA PHARMACEUTICALS INC

Filed

November 23, 2020

Period of Report

November 23, 2020

Accession Number

0001564590-20-054888

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →